Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 20:31:54 GMT 2025
by
admin
on
Mon Mar 31 20:31:54 GMT 2025
|
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
ZE22NE22F1
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000184169
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
||
|
WHO-VATC |
QB02BD06
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
||
|
WHO-ATC |
B02BD10
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
||
|
WHO-ATC |
B02BD06
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
||
|
NCI_THESAURUS |
C78311
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
VONCENTO (AUTHORIZED: HEMOPHILIA A)
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
||
|
FDA ORPHAN DRUG |
424814
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
||
|
WHO-VATC |
QB02BD10
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
D014841
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
C81465
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
100000090387
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
11274
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
ALTERNATIVE | RxNorm | ||
|
N0000175979
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | Increased Coagulation Activity [PE] | ||
|
SUB72116
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
826072
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
109319-16-6
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
GENERIC (FAMILY) | |||
|
ZE22NE22F1
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
Von Willebrand Factor
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
DB13133
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
N0000009524
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | Increased Platelet Aggregation [PE] | ||
|
N0000007914
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | Blood Coagulation Factors [Chemical/Ingredient] | ||
|
ZE22NE22F1
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
N0000171498
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | von Willebrand Factor [Chemical/Ingredient] |
| From | To |
|---|---|
| 1_4 | 1_45 |
| 1_13 | 1_41 |
| 1_47 | 1_58 |
| 1_104 | 1_233 |
| 1_135 | 1_230 |
| 1_297 | 1_321 |
| 1_308 | 1_348 |
| 1_363 | 1_367 |
| 1_386 | 1_406 |
| 1_390 | 1_402 |
| 1_433 | 1_436 |
| 1_471 | 1_474 |
| 1_509 | 1_695 |
| 1_906 | 1_907 |
| 1_923 | 1_1109 |
| 1_1116 | 1_1141 |
| 1_1136 | 1_1177 |
| 1_1164 | 1_1325 |
| 1_1187 | 1_1322 |
| 1_1209 | 1_1360 |
| 1_1230 | 1_1238 |
| 1_1961 | 1_2011 |
| 1_1976 | 1_2025 |
| 1_1987 | 1_2041 |
| 1_1991 | 1_2043 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_94 |
| N | 1_384 |
| N | 1_468 |
| N | 1_752 |
| N | 1_811 |
| N | 1_1460 |
| N | 1_1527 |
| N | 1_1594 |
| N | 1_1637 |
| N | 1_1784 |
| N | 1_1822 |
| N | 1_2027 |
| O | 1_485 |
| O | 1_492 |
| O | 1_493 |
| O | 1_500 |
| O | 1_705 |
| O | 1_714 |
| O | 1_723 |
| O | 1_724 |
| O | 1_916 |
| O | 1_1535 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ENZYME->SUBSTRATE |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
|
||
|
SUBSTRATE -> TARGET |
ADAMTS-13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) is a constitutively active enzyme that cleaves von Willebrand factor (VWF) at the Tyr1605–Met1606 bond in the A2 domai
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|